Home » Newsletters » BioWorld Science

BioWorld Science

June 5, 1998

View Archived Issues

Evaluation of rolipram in experimental animal models of colitis

Cantab: Q1 1998 highlights

Vertex updates shareholders at annual meeting

Xechem receives notice of allowance for paclitaxel analogues

Milkhaus granted U.S. patent for amyloid plaque-reducing agent

Company Profile: InKine

Unimed granted patent coverage for dronabinol use as dementia therapy

Fenofibrate capsules now available in U.S.

Ditropan XL effectively controls urge incontinence in phase III trial

FDA approves PrefGel for periodontal surgery preparation

Zyrtec approved for use in children as young as two years

Genzyme Molecular Oncology and Dana-Farber agreement for fusion cell technology

Pharmacological profile of a selective ETA antagonist

Valaciclovir reduces opportunistic infections in transplant recipients

Amylin: Q1 1998 highlights

Lilly initiates clinical development of tomoxetine for ADHD

Novel series of 5-HT1F agonists under study at Lilly

Cryptophycins for cancer, fungal infections described in patent literature

Synthelabo discloses new agents for urinary incontinence

Series of dopamine receptor subtype-selective ligands developed at Pfizer

Fujisawa compounds lower blood cholesterol, triglyceride and lipid levels

Reversal of diabetes-induced cardiac fibrosis with pirfenidone obtained in animal model

Candesartan reduces infarct size in pig model of myocardial ischemia

LU-302872, an orally active ETA/ETB antagonist for the treatment of BPH

Cardioprotective properties found for pranidipine, a long-acting Ca antagonist

Preclinical and clinical profile of lercanidipine detailed at recent congress

FDA advisory committee recommends approval of new indication for Hycamtin

Teijin expands overseas to support development of TEI-6720

Clinical protocol for phase I/II testing of tgAAV-CFTR

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...